Concepedia

Gérard Valette

GV

3

Publications

189

Citations

3

H-Index

1977

Active since

Affiliations

Sanofi (France)(Current)

Gérard Valette is an author at Sanofi (France) specializing in neuropharmacology, pharmacotherapy, and drug discovery.

Top concepts

Publications per year

1977–2004

3

Publications

3

SR120819A, an orally‐active and selective neuropeptide Y Y1 receptor antagonist

Claudine Serradeil‐Le Gal, Gérard Valette, Pierre-Eric Rouby et al. · FEBS Letters · 1995 · 112 citations · Full text

, , +15

SSR126768A (4-Chloro-3-[(3 R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2- oxo-2,3-dihydro-1 H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, Hydrochloride): A New Selective and Orally Active Oxytocin Receptor Antagonist for the Prevention of Preterm Labor

Claudine Serradeil‐Le Gal, Gérard Valette, Loïc Foulon et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 54 citations

Hyperbasic Media; Synthesis of 1-Alkyl-3-oxocyclohexenes from 1,5-Diketones

M. LARCHEVÊQUE, Gérard Valette, THERESE CUVIGNY · Synthesis · 1977 · 23 citations

, , +2

Rows per page

1–3 of 3